Cytonus Therapeutics, Inc. — Form D
Cytonus Therapeutics, Inc. of Carlsbad, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-30. The offering totals $1.0M, of which $100K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-04-30
- Form: D
- Accession: 0001761468-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $100K
- Remaining: $900K
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2020-04-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-366053
Issuer
- Name: Cytonus Therapeutics, Inc.
- CIK: 0001761468
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3280 Grey Hawk Ct., Carlsbad, CA, 92010
- Phone: 631-258-4070
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Remo Moomiaie | Director | Carlsbad, CA |
| Remo Moomiaie | Executive Officer | Carlsbad, CA |
| Richard Klemke | Director | Carlsbad, CA |
| Richard Klemke | Executive Officer | Carlsbad, CA |
| Jae An | Director | Carlsbad, CA |
| Christopher Thorne | Director | Carlsbad, CA |
| Manisha Narasimhan | Director | Columbus, OH |
Other filings by this issuer (4)
More